XML 266 R22.htm IDEA: XBRL DOCUMENT v3.20.1
Investments in joint ventures (Notes)
12 Months Ended
Dec. 31, 2019
Separate Financial Statements [Abstract]  
Investments in joint ventures
Investments in joint ventures
The following table provides aggregated summarized financial information relating to the group’s share of joint ventures. In December 2019, BP and Bunge both contributed their Brazilian biofuels and biopower businesses into a new joint venture, BP Bunge Bioenergia. BP owns 50% of the new entity.
 
 
 
 
$ million

 
 
2019

2018

2017

Sales and other operating revenues
 
14,139

13,258

11,380

Profit before interest and taxation
 
975

1,396

1,394

Finance costs
 
111

85

100

Profit before taxation
 
864

1,311

1,294

Taxation
 
288

414

117

Profit for the year
 
576

897

1,177

Other comprehensive income
 
(6
)
6

8

Total comprehensive income
 
570

903

1,185

Non-current assets
 
13,408

10,399

 
Current assets
 
3,738

2,935

 
Total assets
 
17,146

13,334

 
Current liabilities
 
2,514

1,715

 
Non-current liabilities
 
4,676

3,017

 
Total liabilities
 
7,190

4,732

 
Net assets
 
9,956

8,602

 
Group investment in joint ventures
 
 
 
 
Group share of net assets (as above)
 
9,956

8,602

 
Loans made by group companies to joint ventures
 
35

45

 
 
 
9,991

8,647

 
Transactions between the group and its joint ventures are summarized below.
 
 
 
 
 
 
 
$ million

Sales to joint ventures
 
 
2019

 
2018

 
2017

Product
 
Sales

Amount receivable at
31 December

Sales

Amount receivable at
31 December

Sales

Amount receivable at
31 December

LNG, crude oil and oil products, natural gas
 
4,884

431

4,603

251

3,578

352

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ million

Purchases from joint ventures
 
 
2019

 
2018

 
2017

Product
 
Purchases

Amount payable at
31 December

Purchases

Amount
payable at
31 December

Purchases

Amount
payable at
31 December

LNG, crude oil and oil products, natural gas, refinery operating costs, plant processing fees
 
1,812

225

1,336

300

1,257

176


The terms of the outstanding balances receivable from joint ventures are typically 30 to 45 days. The balances are unsecured and will be settled in cash. There are no significant provisions for doubtful debts relating to these balances and no significant expense recognized in the income statement in respect of bad or doubtful debts. Dividends receivable are not included in the table above.